uridine diphosphate glucuronic acid and piperidines

uridine diphosphate glucuronic acid has been researched along with piperidines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Atal, CK; Dubey, RK; Singh, J	1
Blum, KA; Brooker-McEldowney, M; Byrd, JC; Dalton, JT; Farley, KL; Fischer, B; Grever, MR; Heerema, NA; Hurh, E; Jarjoura, D; Johnson, AJ; Lin, TS; Mitchell, SM; Moran, ME; Phelps, MA; Rozewski, DM; Schaaf, LJ; Wu, D	1
Christopher, LJ; Hong, H; Humphreys, WG; Iyer, RA; Ma, L; Su, H; Yao, M	1

Trials

1 trial(s) available for uridine diphosphate glucuronic acid and piperidines

Article	Year
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia. Blood, 2009, Mar-19, Volume: 113, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cell Cycle; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Inactivation, Metabolic; Infusions, Intravenous; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Models, Biological; Piperidines; Protein Kinase Inhibitors; Recurrence; Salvage Therapy; Treatment Outcome; Tumor Lysis Syndrome; Uridine Diphosphate Glucuronic Acid; Vidarabine	2009

Article

Year

Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.

Blood, 2009, Mar-19, Volume: 113, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Cell Cycle; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Flavonoids; Humans; Inactivation, Metabolic; Infusions, Intravenous; Injections, Intravenous; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Middle Aged; Models, Biological; Piperidines; Protein Kinase Inhibitors; Recurrence; Salvage Therapy; Treatment Outcome; Tumor Lysis Syndrome; Uridine Diphosphate Glucuronic Acid; Vidarabine

2009

Other Studies

2 other study(ies) available for uridine diphosphate glucuronic acid and piperidines

Article	Year
Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content. The Journal of pharmacology and experimental therapeutics, 1986, Volume: 236, Issue:2 Topics: Alkaloids; Animals; Benzodioxoles; Benzopyrenes; Cell Survival; Epithelium; Galactosamine; Glucuronates; Glucuronosyltransferase; Guinea Pigs; In Vitro Techniques; Intestine, Small; Kinetics; Male; Piperidines; Polyunsaturated Alkamides; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Sugars	1986
In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:9 Topics: Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; ErbB Receptors; Glucuronosyltransferase; Hepatocytes; Humans; Microsomes, Liver; NADP; Piperidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Triazines; Uridine Diphosphate Glucuronic Acid	2011

Article

Year

Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content.

The Journal of pharmacology and experimental therapeutics, 1986, Volume: 236, Issue:2

Topics: Alkaloids; Animals; Benzodioxoles; Benzopyrenes; Cell Survival; Epithelium; Galactosamine; Glucuronates; Glucuronosyltransferase; Guinea Pigs; In Vitro Techniques; Intestine, Small; Kinetics; Male; Piperidines; Polyunsaturated Alkamides; Uridine Diphosphate Glucuronic Acid; Uridine Diphosphate Sugars

1986

In vitro characterization of the metabolic pathways and cytochrome P450 inhibition and induction potential of BMS-690514, an ErbB/vascular endothelial growth factor receptor inhibitor.

Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:9

Topics: Cells, Cultured; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; ErbB Receptors; Glucuronosyltransferase; Hepatocytes; Humans; Microsomes, Liver; NADP; Piperidines; Pyrroles; Receptors, Vascular Endothelial Growth Factor; Triazines; Uridine Diphosphate Glucuronic Acid

2011